Therefore, identification of a discrete HTT-Rab4-vesicle population has important implications for how defects in axonal transport contributes to HD pathology, highlighting Rab4 and the endosomal pathway as a potential novel therapeutic target for early intervention prior to neuronal loss and behavioral defects observed in HD. The gene discussed is RAB4B; the disease is Huntington disease.